Analytical testing, QC

COVID-19 tools from Cerba aim to save researchers time

28-Jan-2021 By Jenni Spinner

The company has released two products designed to help clinical researchers accelerate development of treatments and vaccines for the COVID-19 virus.

Calyx spins off medical imaging, eClinical solutions firm

19-Jan-2021 By Jenni Spinner

Formerly Parexel Informatics, the renamed clinical research technology company has broken off and will operate as an independent company going forward.

Lonza scientific team on the hunt for pharma fakery

13-Jan-2021 By Jenni Spinner

The company’s Forensic Chemistry Group comprises a collection of technical professionals using their respective talents to detect and thwart counterfeiting.

PRA Health Sciences expands COVID-19 monitoring program

11-Jan-2021 By Jenni Spinner

The CRO is working with PWNHealth and Fulgent Genetics to enhance its monitoring program, including the addition of at-home COVID-19 testing capabilities.

First FDA COVID-19 update of 2021

04-Jan-2021 By Jenni Spinner

As healthcare providers and other high-priority patients begin receiving the vaccines, the agency continues to act to help the national pandemic response.

DNA analysis could pinpoint ‘long haulers’ among COVID-19 patients

23-Dec-2020 By Jenni Spinner

The analytical tool, developed via Bionano Genomics, maps structural variations in DNA that are known to cause disease and are tied to symptom severity.

COVID-19 response platform expands reach across US

22-Dec-2020 By Jenni Spinner

The GoGetTested response operating system, to date used to administer more than 200,000 tests, now will scale to include health systems in more states.

Chicago life-sciences incubator to open in early 2021

14-Dec-2020 By Jenni Spinner

The resource—designed to provide seed capital, lab space, offices and management consulting to researchers—is opening its doors earlier than expected.

Ancestry study explores COVID-19 genetic risks

07-Dec-2020 By Jenni Spinner

The online DNA network has delved into self-reported data of more than 563,000 US adults to help identify genetic risk of infection and severe outcomes.

Scottish biotech outfit launches clinical trials division

24-Nov-2020 By Jenni Spinner

Intelligent Tissue Group has launched its Intelligent Clinical trials facility to help assess the effectiveness and safety of potential new treatments.

Phesi: protocol changes slow COVID-19 trial down

17-Nov-2020 By Jenni Spinner

A leader from the clinical services provider shares insights gained from comparing two COVID-19 vaccine trials, and tales told by the differences.

Metabolic-disease CRO poised for growth

02-Nov-2020 By Jenni Spinner

With an infusion of capital from investors 1315 Capital, ProSciento is setting its sights on expansion of its specialized clinical research services.

FDA COVID-19 advice and announcements this week

28-Oct-2020 By Jenni Spinner

The latest coming from the agency includes word of the first FDA-approved treatment for the virus, template for test developers and other resources.

ACD/Labs analytical platforms upgraded for COVID-19 age

15-Oct-2020 By Jenni Spinner

The company's Spectus and Percepta platforms offer features to help researchers meet challenges associated with working and collaborating in the pandemic.

Current FDA COVID-19 advice and actions

14-Oct-2020 By Jenni Spinner

The federal government continues to offer life-sciences professionals advice and resources as they pursue treatments to help fight the COVID-19 virus.

CPhI Festival of Pharma

Vetter to profile cleanroom concept at CPhI

30-Sep-2020 By Jenni Spinner

The aseptic technology specialist plans to discuss its V-CRT cleanroom technology at the upcoming CPhI Festival of Pharma online event in October.

Latest COVID-19 news from the FDA

17-Sep-2020 By Jenni Spinner

The US agency continues to issue advice for life-sciences professionals engaged in work related to the virus, and keep an eye out for fraudulent products.

Daxor research battles military injuries

10-Sep-2020 By Jenni Spinner

The company is delving into clinical research partnerships geared toward saving the lives of soldiers, eventually translating findings to civilian care.

Thermo Fisher expands cryo-EM access

31-Aug-2020 By Jenni Spinner

The company intends to enable pharma and biotech companies to have greater access to cryo-electronic microscopy for their research projects.

Breaking FDA COVID-19 news

26-Aug-2020 By Jenni Spinner

The agency continues to take actions and issue advice related to COVID-19 treatments, tests, consumer products and other pressing industry concerns.

Mission Bio raises $70m to help develop cancer therapies

17-Aug-2020 By Jenni Spinner

The company has landed $70m in Series C funding, with the purpose of accelerating development of cancer therapies with single-cell multiomics.

Current FDA COVID-19 news

13-Aug-2020 By Jenni Spinner

The US federal agency continues to keep busy offering resources, issuing EUAs and taking action related to the COVID-19 pandemic.

Lab gears up to support COVID-19 trials

04-Aug-2020 By Jenni Spinner

Researchers at ACM Global Laboratories are focused on aiding clinical trials working on treatments for the deadly virus behind the current pandemic.

Most recent FDA COVID-19 updates

30-Jul-2020 By Jenni Spinner

The US agency continues to put out informational resources, issue EUAs for tests and treatments, and monitor industry activity related to the virus.

People on the Move: June 2020

03-Jun-2020 By Jenni Spinner

This month’s roundup of new hires, promotions and awards involves Gilead Sciences, Cardiff Oncology, Science 37, and other notable firms.

Diamond Pharma Services acquires PharmaCentral

12-May-2020 By Jenni Spinner

The purchase of the Irish pharmacovigilance specialist is intended to expand’s Diamond’s European presence, and increase its senior-level industry expertise.

Berg, Boehringer Ingelheim partner on inflammatory disease research

06-May-2020 By Jenni Spinner

The research collaboration will seek to identify candidate biomarkers for a group of inflammatory conditions, using AI and other advanced technology.

Butterworth Labs adopts COVID-19 crisis measures

27-Apr-2020 By Jenni Spinner

The pharmaceutical analysis firm is continuing its contract analytical laboratory services running, with changes designed to keep people and products safe.

Vanda Pharmaceuticals partners with UIC on COVID-19 research

21-Apr-2020 By Jenni Spinner

The company and the University of Illinois at Chicago will work together to identify novel antivirals against COVID-19.

MedPharm donates hand sanitizer to combat COVID-19

31-Mar-2020 By Jenni Spinner

The company has shifted production to manufacture sanitizer, intended to protect healthcare providers and other essential workers from coronavirus.

Gates Foundation enlists Novartis, GSK, others in COVID-19 fight

27-Mar-2020 By Jenni Spinner

The global collaboration brings together several pharmaceutical giants to accelerate the development and delivery of coronavirus tests and therapies.

zPredicta, LabCorp partner on 3D cell culture technology

26-Mar-2020 By Jenni Spinner

The collaboration supports the adoption of zPredicta’s 3D cell culture platform for preclinical testing and research studies.

FDA roundup of COVID-19 responses

25-Mar-2020 By Jenni Spinner

The federal agency has been busy in recent weeks, taking actions and issuing advice in the face of the global coronavirus pandemic.

PolarisQB, Fujitsu partner on drug discovery

24-Mar-2020 By Jenni Spinner

The two companies are combining their technologies to speed the process of bringing to market treatments for Dengue fever and other diseases.

Pharma events update: rescheduled, canceled, online

18-Mar-2020 By Jenni Spinner

This list includes the industry events that have been postponed or moved because of the coronavirus pandemic.

Agilex expands bioanalytical labs capacity to meet US, APAC demand

17-Mar-2020 By Vassia Barba

Agilex has expanded its bioanalytical laboratories by 30%, in order to accommodate demand coming mainly from US and APAC-based biotech companies.

QPS launches access-restricted laboratory

16-Mar-2020 By Jenni Spinner

The access-restricted bioanalysis lab will support research to develop treatments and vaccines for novel coronavirus and other viruses.

Altasciences acquires Alliance Contract Pharma

12-Mar-2020 By Jenni Spinner

The contract research organization has purchased Alliance Contract Pharma, a small-molecule contract manufacturing and analytical firm.

Genomic computation platform launches on Microsoft Azure

10-Mar-2020 By Vassia Barba

EPAM Cloud Pipeline, a cloud software application, is available on Microsoft Azure to support developers manage ‘constantly changing’ demands in analytics and modeling.

Thermo Fisher Scientific sets sights on Qiagen acquisition

10-Mar-2020 By Jenni Spinner

The purchase is aimed at expanding the company’s specialty diagnostics offerings in sample preparation technology, assay capabilities, bioinformatics and more.

Medidata in deal on AI biomarker identification for ALS developments

09-Mar-2020 By Vassia Barba

Project ALS has selected Medidata’s biomarker discovery solution for its research projects, aiming to improve understanding of the ALS disease process and develop new therapeutic strategies.

Lunac, Domainex join forces on anticoagulant discovery ‘urgent need’

05-Mar-2020 By Vassia Barba

Domainex is set to support Lunac’s discovery project for anticoagulant therapies with reduced bleeding risk, following the developer’s novel target validation.

Frontage continues build-out to meet late-stage developers demand

27-Feb-2020 By Vassia Barba

Frontage has announced completion of its Pennsylvania site expansion to boost its offering of bioanalytical services for late-stage cell and gene therapies developers.

CRO ‘adding expertise’ to respond to the evolution of biometrics

06-Feb-2020 By Vassia Barba

Acquisition of Clindata’s human health biometrics division is expected to increase Synteract’s geographical footprint along with the adaptability of its biometrics services solutions.

Vetter consolidates development labs in one location

04-Feb-2020 By Ben Hargreaves

Vetter decides to house its development laboratories together in Ravensburg, Germany, to modernize capabilities, with plans for further expansion.

CROs partner on joint discovery platform to accelerate R&D projects

04-Feb-2020 By Vassia Barba

Leveraging Eurofins’ pharmacology, in-vitro models and ADME capabilities, PharmaResources aims to accelerate drug discovery for its clients in small molecule drug R&D.

FDA puts spotlight on compounded drugs, opens educational center

07-Jan-2020 By Vassia Barba

In an aim to improve quality assurance and control of compounded medicine, the US FDA opens a Compounding Quality Center of Excellence.

Combined in-vivo and in-vitro capabilities for faster efficacy assessment

23-Dec-2019 By Vassia Barba

Amylgen and Neuron-Experts partner to create a comprehensive offering of in-vivo and in-vitro efficacy evaluation for compounds in neurodegenerative diseases.

Metrion and LifeArc extend collaboration on neurological target

17-Dec-2019 By Vassia Barba

After one year of collaborative work, Metrion and LifeArc agree to continue research on a joint project focused on neuroscience ion channel drug discovery for another year.

Thermo Fisher expands site, boosts biologics processing offering

28-Nov-2019 By Vassia Barba

Thermo Fisher Scientific doubles the capacity of its gene therapy and viral vector processing facility in Alachua, Florida, to provide scalability to customers.